Market Research Blog

According to a recent report by Future Market Insights, sales of hemp milk are estimated to reach a value of US$ 236.4 Mn by 2032, surging at 7.3% CAGR through the decade.

Rising awareness regarding the functional benefits of plant-based food and beverage products is expected to drive sales of hemp milk over the forecast period. Manufacturers are launching a wide variety of hemp milk such as unsweetened, flavoured and non-flavoured options.

Further, consumers are getting more aware of the health benefits of hemp milk. It contains omega-3 fatty acids, protein, vitamins, and is low in fat, making it a desirable substitute to conventional dairy milk.

Hemp milk is also a great source of minerals and vitamins like calcium, iron, and others, which has increased its popularity among fitness enthusiasts. Growing consumption of ready-made foods and beverages, along with high preference for organic and clean-label products will augment the growth in the market.

Get | Download Sample Copy with Graphs & List of Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14596

“Increasing incorporation of hemp milk in the foodservice sector is expected to fuel demand in the market in the forthcoming years. Besides this, growing popularity of veganism across emerging economies will boost sales over the forecast period,” says and FMI analyst.

Key Takeaways from Market Study

• Sales of hemp milk in the U.S. are projected to increase at a 5.7% CAGR, accounting for a dominant share of the North America hemp milk market.
• Demand in the Italy hemp milk market are forecast to grow at a 11.7% CAGR over the forecast period.
• In terms of sales channel, total sales in the offline segment are projected to hold more than 3/4^th of the market share in 2022.

Competition Landscape

Some of the leading players in the hemp milk market include Drink Daily Greens LLC, PACIFIC FOODS OF OREGON, LLC., Wild Harvest, Good Hemp Food, Cell-Nique Corporation, The Fix Juice Pty Ltd, Organic Hemp Milk Australia, Manitoba Harvest Hemp Foods, Goodmylk Co., Ecomil, milkadamia, and Victory Hemp Foods.

Key players operating global hemp milk market are investing in partnerships and collaborations with other manufacturers in order to expand their product manufacturing facilities. For instance:

• SunOpta announced in February that it had purchased Dream and WestHemp from the Hain Celestial Group, two of the largest and most established brands in the shelf-stable plant-based dairy products sector. SunOpta increased its beverage plant capacity in Allentown, Pennsylvania.

Browse Full Report@ https://www.futuremarketinsights.com/reports/hemp-milk-market

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of hemp milk presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

Hemp Milk Market by Category

By Form:

• Liquid
• Powder

By Flavor Type:

• Original/Unflavoured
• Flavoured
  • Chocolate
  • Vanilla
  • Other Flavours

By End-Use:

• Dairy Products
  • Cheese
  • Yoghurt
  • Butter
  • Spreads
  • Ice Cream
  • Frozen Dessert
• Bakery and Confectionery
• Milk & Milk Based Beverages
• Retail Sales

By Sales Channel:

• Direct Sales
• Indirect Sales
  • Modern Trade
  • Convenience Store
  • Departmental Store
  • Traditional Store
  • Specialty Store
  • Online Retailers
  • Other Sales Channel

By Region:

• North America
• Latin America
• Europe
• Middle east and Africa
• East Asia
• South Asia
• Oceania

Ask Our Analyst More about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-14596

Frequently Asked Questions

• At what rate will the hemp milk market grow?
• What are the key factors driving the hemp milk market?
• Which is the most attractive region in the global hemp milk market?
• Who are the key players in the hemp milk market?

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse Other Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

The global freeze-dried food market is set to witness growth at a CAGR of 6.8% over the forecast period, reaching a valuation of US$ 54.8 Bn by 2032.

Increasing awareness about various health benefits of nutritional, natural, and low carb diet is fuelling the demand for freeze-dried fruits and vegetables.  One of the key factors driving the market is prolonged shelf-life of freeze-dried fruits without any synthetic ingredient or preservatives.

Regular consumption of freeze-dried fruits can help in reducing the risk of cardiovascular diseases, liver and colon cancer, and other ailments. With rising health concerns among consumers, freeze-dried fruits manufacturers are launching innovative products to benefit from the ongoing trend.

Freeze-dried food is prone to contamination by toxigenic fungi and bacteria as they contain various parts of aromatic and medicinal plants such as flowers, seeds, stems, leaves, and roots which can degrade over time.

These foods are produced with powdered amalgams of various herbal plants which might produce toxins. This is increasing the chances of certain risk factors involved with the consumption of freeze-dried fruits, which might restrict sales in the market to an extent.

Click the link to get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14595

Freeze-dried food manufacturers are becoming more conscious during the process cycles of freeze-dried fruits and are focusing on a thorough examination of herbal and aromatic plants to reduce the chances of contamination.

“Increasing sales of functional foods and dietary supplements in driving the adoption of freeze dried fruits and vegetables in the nutraceuticals sector. In addition to this, manufacturers are striving to achieve optimal processing methods to reduce the chances of contamination within these products, which is expected to steer the growth in the market,” says an FMI analyst.

Key Takeaways:

• Sales in the North America freeze dried food market are expected to account for 25% of the total market share in 2022.
• East Asia will emerge as a lucrative pocket owing to expansion of the food and beverage sector in countries such as China, India, and Japan.
• Based on product type, freeze-dried fruits segment is expected to account for a dominant share of the global market in 2022.
• In case of end use segment, sales in the food and beverage sector are forecast to remain high through 2032.
• By sales channel, the B2B segment will emerge as a lucrative segment over the assessment period.

Competitive Landscape

Nestle S.A., Kerry Group Plc, European Freeze Dry, OFD foods LLC, Molda AG, and others are some of the leading freeze dried food market players profiled by FMI.

Manufacturers operating in the global freeze dried food market are adopting various marketing strategies such as new product launches, geographical expansion, merger and acquisitions, partnerships and collaboration to identify the interest of potential buyers and to improve sales. For instance:

• In 2020, Nestle introduced a simple solution known as “nesQino”. This aids the consumers to personalize their choices of healthy superfood and beverage made from 100% natural ingredients.

Browse Full Report@ https://www.futuremarketinsights.com/reports/freeze-dried-food-market

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the global freeze-dried food market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

Global Freeze- Dried Food Market By Category

By Product Type:

• Fruits
  • Strawberry
  • Raspberry
  • Pineapple
  • Apple
  • Mango
  • Other Fruits
• Vegetables
  • Carrot
  • Potato
  • Corn
  • Pea
  • Mushroom
  • Other Vegetables
• Freeze-Dried Dairy Products
• Freeze-Dried Meat and Seafood
• Freeze-Dried Pet Food
• Prepared Meal

By Nature:

• Organic
• Conventional

By Form:

• Powdered
• Granules
• Diced

By End Use:

• Food & Beverages Products
  • Breakfast Cereals
  • Dairy Products
  • Bakery & Confectionery
  • Nutritional Bars & Supplements
  • Powdered Beverages
  • Snacks
• Retail (household)

By Distribution Channel:

• B2B
• B2C
  • Hypermarkets/Supermarkets
  • Convenience Store
  • Specialty Store
  • Food & Drinks Specialty Store
  • Independent Small Grocery Store
  • Online Retail

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Ask Our Analyst More about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-14595

Frequently Asked Questions

• What is the current freeze dried food market size?
• At what rate is the global freeze-dried food market expected to grow?
• What is the share of the top 10 companies in the freeze-dried food market?
• Which countries are driving demand for freeze-dried food?

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse Other Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the global protein A resins market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 536.6 Mn in 2020 to over US$ 1.2 Bn by 2031. This reflects a cumulative CAGR of around 8.1% over the forecast period (2021-2031).

Increasing research conducted on monoclonal antibodies are driving demand for protein A resin. Since the commercialization of the first therapeutic monoclonal antibody in 1986, till May 2021, around 100 monoclonal antibody products have been approved by the U.S. FDA and European Medical Agency for the treatment of various diseases such as cancer.

Monoclonal antibody therapy for the treatment of mild to moderate COVID-19 in patients has also been approved by the FDA under Emergency Use Authorization (EUA).

Studies on monoclonal antibodies have indicated that more monoclonal antibody therapies are in the process of getting FDA approval and can be marketed in the near future to cater to rising demand in the global life sciences industry. Thus, increasing research on monoclonal antibodies (mAb) is expected to fuel the demand and utilization of protein A resin for purification and precipitation purposes.

For the purification of monoclonal antibodies (mAb), different technologies are available which includes membrane chromatography, mixed chromatography, and aqueous two-phase extractions (ATPS). However, protein A resin holds the top position for the purification of mAbs.

With many industries facing issues of leaching of ligand and resistance during the commercialization of monoclonal antibodies (mAbs), the availability of next-generation protein A resins with improved purification conditions, such as alkaline-stability, and with very low ligand leaching, is expected to increase the production and throughput demand for protein therapeutic processes.

Furthermore, in June 2018, Purolite Life Sciences launched a novel next-generation Protein A agarose resin, Praesto Jetted A50. GE Healthcare, in 2017, introduced a next-generation protein A resin, MabSelect PrismaA, which was designed to enable biopharma manufacturers to improve their mAb purification capacity by up to 40% over GE Healthcare’s existing protein A affinity medium. These product launches are expected give tailwinds to growth registered in the market.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1720

Key Takeaways from Protein A Resin Study

• By product, the natural protein A resin hold the maximum share of 62.8% in 2021. Natural protein A is derived from a bacterial cell of the staphylococcus aureus species and mainly used in the purification of monoclonal antibodies.
• By matrix, the agarose based matrix of protein A resin account for 85.8% of the market share in 2021 indicating the highest demand, offering high binding specificity when in comparison to other matrices and are widely used for the attachment of ligands that bind proteins.
• By application, the antibody purification of protein A resin segment will account for 74.8% of the market share in 2021.
• By end user, the biopharmaceutical manufacturers will account for 79.2% of the market share in 2021.
• By region, North America held the largest share of 35.7% of the global protein A resins market in 2021.
• The U.S. will emerge as a leading market in North America, while growth registered in Europe will be spearheaded by Germany and the U.K.

“Increasing demand of protein A Resins for biologics production including monoclonal antibody and biosimilars is expected to drive the demand of protein a resin over the decade. To capitalize on existing opportunities, market players are expected to push investment towards product launches and research initiatives,” says the FMI Analyst

Who is Winning?Some of the leading manufacturers of protein A resin market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

• In August 2021, Danaher Corporation acquired Aldevron and stated that Aldevron will work as a stand-alone operating firm and brand within the life sciences segment of Danaher to provide a vast range of custom biologic services, including plasmid DNA production, mRNA production, and antibody development.
• On 11 February 2021, Thermo Fisher Scientific Inc. started the online offering of its essential Thermo Scientific Dionex Easion and Thermo Scientific Dionex Aquion Ion Chromatography (IC) systems through easy online ordering.  This step was undertaken in order to reduce the in-person transaction during the pandemic.
• In October 2020, Kaneka Corporation collaborated with the biomedical research institute “de Duve Institute” of the University of Louvain, wherein they signed a research collaboration agreement in order to develop innovative biomedicine production technologies and strengthen and expand the company’s current biomedicine CDMO business.
• In April 2020, Bio-Rad Laboratories, Inc. launched a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19.

The key market players covered by FMI include :

• GE Healthcare
• Thermo Fisher Scientific
• Kaneka Corporation
• JNC Corporation
• Purolite Life Sciences
• Bio-Rad Laboratories Inc.
• JSR Corporation (JSR Life Sciences LLC)
• Repligen
• Tosoh Bioscience
• Merck Group (Merck Millipore)
• Novasep Holdings SAS
• Agilent Technologies Inc.
• GenScript
• Abcam PLC (Expedeon Ltd.)
• Avantor Inc.
• Takara Bio
• PerkinElmer Inc.
• Suzhou Nanomicro Technology Co. Ltd.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1720

Key Segments:

Product:

• Natural Protein A Resin
• Recombinant Protein A Resin

Matrix:

• Agarose Based Matrix
• Glass or Silica Based Matrix
• Organic Polymer Based Matrix

Application:

• Immunoprecipitation
• Antibody Purification

End User:

• Biopharmaceutical Manufacturers
• Clinical Research Laboratories
• Academic Institutes

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

• https://techplanet.today/post/nasal-spray-market-report-size-growth-demand-scope-opportunities-and-forecast-2022-2032
• https://ai.ceo/read-blog/15757_nasal-spray-market-report-size-growth-demand-scope-opportunities-and-forecast-20.html
• https://adhipatialumni.com/blogs/61273/Nasal-Spray-Market-Report-Size-Growth-Demand-Scope-Opportunities-and
• https://waoop.com/read-blog/33897_nasal-spray-market-report-size-growth-demand-scope-opportunities-and-forecast-20.html
• https://anotepad.com/notes/y6hnw27p

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The global specialty Active Pharmaceutical Ingredients (API) market reached US$ 152.5 Bn in 2019, up by 8.5% in 2018.

An increase in the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease has boosted the demand for specialty active pharmaceutical ingredients (API).

Manufacturers are on the continuous lookout to produce new small molecule APIs. This is expected to give an impetus to the specialty active pharmaceutical ingredients (API) market during the forecast period.

Increasing investments in the specialty active pharmaceutical ingredients (API) market by key players and new technology development for low-cost production of generic drugs are the major factors expected to drive the market growth.

Key Takeaways of Specialty Active pharmaceutical ingredients (API) Market Study

• Increasing demand in the production of generic drugs is likely to fuel demand for small molecules
• Europe, followed by North America, is expected to be the most lucrative region and account for a notable revenue share of about 29% in the global specialty active pharmaceutical ingredients (API) market in 2020 and trend is expected to continue owing to large number of drugs going off-patent during forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1719

High patient population and growing pharmaceutical contract manufacturing organizations in Asian countries is expected to propel the growth of the specialty active pharmaceutical ingredients (API) market in the region

“Continuous focus on the development of low-cost specialty active pharmaceutical ingredients (API) and increasing incidence of infectious and metabolic diseases around the world are expected to propel the growth of the global specialty active pharmaceutical ingredients (API) market,” says an FMI Analyst.

Increasing Research Collaboration – Imperative Strategy for Market Players

Manufacturers are now focusing on discovering and developing new drug candidates through research collaborations and license agreements for the treatment of cardiovascular diseases, lung diseases and the other chronic diseases.

For instance, in March 2020, Bayer signed a research collaboration and license agreement with Indian drug discovery firm Curdev to discover novel drug candidates.

Specialty API Market Witnessing a Paradigm Shift

Shift of Specialty API Market from Type I DMFs (Drug Master Files) to Type II DMFs is expected to further drive market growth. Type II DMF drug encloses drug substances, substance materials and intermediates used in drug product’s penetration.

Extensive DMF filings are reflected through API manufacturers envisaging the steep increase in demand for outsourcing intermediates or APIs. DMF filings could also be attributed to growing investments for enhancing production facilities on the part of manufacturers based in Asia Pacific.

Also, regulatory agencies such as SAHPRA, Brazilian Health Regulatory Agency, MHRA, TGA, and U.S. FDA are in a DMF approval mode; thereby acting as another driving factor.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1719

Covid-19 to Stall Short-term Momentum

The outbreak of Covid-19 has not left any vertical untouched,  and specialty API market is no exception. Certain manufacturers are dependent on China for APIs. This influx has slowed down due to this ongoing pandemic. The trend is expected to continue at least for the next few months till manufacturers come up with an alternative to by in sync with the “new” normal.

What else is in the report?

Future Market Insights offers a unique perspective and actionable insights on specialty active pharmaceutical ingredients (API) market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (small molecules, peptides, carbohydrate drugs and steroidal drugs), by consumption (in-house and outsourced) in seven key regions.

Key Segments of Specialty Active Pharmaceutical Ingredients (API) Market

Product Type

• Small Molecules API
  • Controlled Substances API
  • HPAPI
• Peptides API
• Carbohydrate Drugs API
• Steroidal Drugs API

Consumption

• In-house
• Outsourced

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1719

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Explore Other Reports Links From Healthcare Market:

• https://www.telecomagent.org/jaydipfmi/nasal_spray_market_report_size_growth_demand_scope_opportunities_and_forecast_2022-2032
• https://www.knowasiak.com/nasal-spray-market-report-size-scope-and-forecast-2032/
• https://finbook.com/blogs/2590/Nasal-Spray-Market-Report-Size-Growth-Demand-Scope-Opportunities-and
• https://club.vexanium.com/post/nasal-spray-market-report-size-growth-demand-scope-opportunities-and-foreca–6388771825393b1c829ac738
• https://www.exoltech.net/blogs/20192/Nasal-Spray-Market-Report-Size-Growth-Demand-Scope-Opportunities-and

About Future Market Insights (FMI):

Future Market Insights (ESOMAR-certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs